Nanoceut Therapeutics Private Limited

Nanoceut Therapeutics Private Limited - chemicals in Sedarapet, Puducherry, India. FY 2026 financials & compliance.
CIN U24230PY2010PTC002523 Incorporated 04 November 2010 ROC Pondicherry HQ Sedarapet, Puducherry, India
Active Private Limited Company chemicals MSME · Small
Revenue · FY 2025
₹14.24 Cr
▼ 11% YoY
Net profit · FY 2025
₹73.08 Lakh
Net margin 5.1%
EBITDA · FY 2025
₹2.48 Cr
EBITDA margin 17.4%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹10.99 Cr
Satisfied ₹10.23 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
93
Provident fund records

About Nanoceut Therapeutics Private Limited

Data last updated:

Nanoceut Therapeutics Private Limited is a private limited company based in Sedarapet, Puducherry, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 04 November 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U24230PY2010PTC002523. Its GSTIN is 34AADCN4335K1ZG (Puducherry).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Krishna Kumar Abboy (Managing Director) and Haripriya.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R.S. No.104/19A E V R Street, Sedarapet, Puducherry, India – 605111.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.24 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹73.08 Lakh (net margin 5.1%) and EBITDA of ₹2.48 Cr (EBITDA margin 17.4%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 6% over five years.

The company has about 93 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Nanoceut. As per MCA filings, the company has open charges of ₹10.99 Cr and satisfied charges of ₹10.23 Cr on record. Court records list 120 cases involving the company, including 113 filed by the company and 7 filed against it; 44 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in May 2014. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Croma Lifescience Private Limited with revenue of ₹14.29 Cr.

Nanoceut Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0002903). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nanoceut.com.

Company details

CIN U24230PY2010PTC002523
Registration Number 002523
Incorporation Date 04 November 2010
ROC Pondicherry
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PY-03-0002903

Recognitions & Rankings of Nanoceut Therapeutics

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-PY-03-0002903

Contact details

Nanoceut Therapeutics Private Limited's registered office is in Sedarapet, Puducherry. Its website is nanoceut.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    R.S. No.104/19A E V R Street, Sedarapet, Puducherry, India – 605111
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals

To see the full contact details of Nanoceut Therapeutics Private Limited, buy the company report.

Comprehensive company report
Nanoceut Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Nanoceut Therapeutics operates one associated brand: Nanoceut. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical contract manufacturing of high-quality products and food supplements is conducted by Nanoceut.nanoceut.com

Business activity

The main business activity of Nanoceut Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Nanoceut Therapeutics Private Limited, buy the company report.

Financials of Nanoceut Therapeutics Private Limited

FY 2025 filings available

Nanoceut Therapeutics Private Limited reported revenue of ₹14.24 Cr (down 11% YoY) for FY 2025.

Revenue · FY 2025
₹14.24 Cr ▼ 11%
Net profit · FY 2025
₹73.08 Lakh margin 5.1%
EBITDA · FY 2025
₹2.48 Cr margin 17.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 1%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 36%
5 years · compounded
▲ 24%

Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.48 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹73.08 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin17.4%
Net Profit Margin5.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nanoceut Therapeutics Private Limited, buy the company report.

Board of directors of Nanoceut Therapeutics Private Limited

Nanoceut Therapeutics has 2 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Krishna Kumar AbboyManaging Director01 Feb 20188 Years 9 MonthsCurrent
HaripriyaDirector26 May 201412 Years 5 MonthsCurrent

Peer comparison

Nanoceut Therapeutics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Croma Lifescience Private Limited₹14.29 Cr (FY 2025)4.0%Pipli, Gujarat, India
Nami Lifesciences Private Limited₹14.27 Cr (FY 2025)0.0%Siddipet, Telangana, India
Phaedrus Life Science Private Limited₹14.25 Cr (FY 2025)14.0%Ahmedabad, Gujarat, India
Nanoceut Therapeutics Private Limitedthis company₹14.24 Cr (FY 2025)₹73.08 Lakh5.1%-11.0%93Sedarapet, Puducherry, India
Marsha Pharma Private Limited₹14.24 Cr (FY 2025)1.0%Vadodara, Gujarat, India

To see the full peer comparison of Nanoceut Therapeutics Private Limited, buy the company report.

Auditor

Nanoceut Therapeutics Private Limited is audited by VIJAYAKUMAR P for the financial year 2024.

Auditor firmFinancial yearFirm registration number
VIJAYAKUMAR PFY 2024243489

Shareholding

The shareholding of Nanoceut Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nanoceut Therapeutics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10.99 Cr
Satisfied charges
₹10.23 Cr
Breakdown by lending institutions
Indian Bank₹9.24 Cr
Sidbi₹1.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Dec 2024101033299Indian Bank₹9.24 CrOpen
25 Apr 2023100718004Sidbi₹1.75 CrOpen
22 Sep 2023100799602Others₹33.4 LakhSatisfied
22 Sep 2023100799582Others₹1 CrSatisfied
29 Apr 2023100741603Others₹5 CrSatisfied

To see the full charge records of Nanoceut Therapeutics Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Nanoceut Therapeutics Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in May 2014.

Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹90 Lakh

Deals on record (3 of 3)

WhenDealAmountParties
May 2014Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals
Mar 2013Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2013Funding round₹90 LakhInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nanoceut Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Nanoceut Therapeutics Private Limited has a workforce of 93 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
93
Active EPFO establishments
1
Employee growth
97.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2793
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Nanoceut Therapeutics Private Limited, buy the company report.

GST

Nanoceut Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
34AADCN4335K1ZGPuducherryActive01 Jul 2017

To see the full GST registrations and return filing status of Nanoceut Therapeutics Private Limited, buy the company report.

Recent activity

Nanoceut Therapeutics Private Limited has 16 board changes on record since 2011: 2 appointments and 14 cessations. The latest: Krishna Kumar Abboy ceased to be Director on 23 Jul 2024.

AGM
Nanoceut Therapeutics Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Indian Bank of Rs. 9.24 Cr registered on 02 Dec 2024 with Charge ID 101033299 was modified on 12 May 2025.
Filing
Nanoceut Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pondicherry.
Charges
A charge registered on 22 Sep 2023 via Charge ID 100799602 with Others was fully satisfied on 02 Jan 2025.
Charges
A charge registered on 22 Sep 2023 via Charge ID 100799582 with Others was fully satisfied on 02 Jan 2025.
Charges
A charge registered on 29 Apr 2023 via Charge ID 100741603 with Others was fully satisfied on 02 Jan 2025.
Charges
A charge with Indian Bank amounted to Rs. 9.24 Cr with Charge ID 101033299 was registered on 02 Dec 2024.
Ceased
Krishna Kumar Abboy ceased to be Director.
Charges
A charge registered on 11 Aug 2022 via Charge ID 100624490 with Sidbi was fully satisfied on 12 Apr 2024.
Charges
A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100799602 was registered on 22 Sep 2023.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100799582 was registered on 22 Sep 2023.
Charges
A charge with Others of Rs. 5.00 Cr registered on 29 Apr 2023 with Charge ID 100741603 was modified on 22 Sep 2023.

22 earlier events are in the company report.

Frequently asked questions

Nanoceut Therapeutics is an active private limited company based in Sedarapet, Puducherry, India. The company works in chemical products, within the chemicals industry. It was incorporated on 04 November 2010 (16+ years old) and is registered under CIN U24230PY2010PTC002523.

Nanoceut Therapeutics has 2 current directors:

The latest financial statements of Nanoceut Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nanoceut Therapeutics is 34AADCN4335K1ZG, registered in Puducherry.

The CIN (Corporate Identification Number) of Nanoceut Therapeutics is U24230PY2010PTC002523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nanoceut Therapeutics has 120 court cases on record: 113 filed by the company and 7 filed against it. 44 are pending. Most are in the district courts.

Nanoceut Therapeutics was incorporated on 04 November 2010, making it 16+ years old. It is registered with the Registrar of Companies, Pondicherry.

Nanoceut Therapeutics has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in May 2014.

The peers of Nanoceut Therapeutics by revenue are Croma Lifescience Private Limited, Nami Lifesciences Private Limited, Phaedrus Life Science Private Limited, Marsha Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Krishna Kumar Abboy ceased to be Director on 23 Jul 2024. Krishna Kumar Abboy was appointed as Managing Director on 01 Feb 2018. Abboy Gunabai ceased to be Additional Director on 30 Sep 2014. Nanoceut Therapeutics has 16 board changes on record in total.

Yes, Nanoceut Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-PY-03-0002903).